Delivery Order SPE2D021DA002-SPE2D325F363G
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,093.62 for the supply of Isentress 400 mg tablets (60-count) to the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a tactical procurement of antiretroviral medication to support Department of Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,280.86 on August 18, 2025, for the supply of Isentress 400 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The award represents a continuation of DMS...
- This delivery order, valued at $1,429.30, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Isentress 400 mg tablets (60-count units). The award was issued on June 6, 2025, under a firm fixed-price contract type with an ultimate completion date of June 11, 2025. The product will be delivered to Park Ridge, Illinois, and the contract was funded by the Defense Logistics Agency's Medical Supply Chain...
- The U.S. Defense Logistics Agency, operating through the Medical Supply Chain division, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for $2,093.62 on September 29, 2025. The order covers 60 tablets of Isentress 400 mg, an antiretroviral medication used in HIV treatment, with delivery to Park Ridge, Illinois and a completion deadline of September 30, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's status as a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of Isentress 400 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical provides a wide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,650.54 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ISENTRESS 100 MG TABLET CHEW UU 60S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, for the supply of Isentress 400 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,093.62. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499.99...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Isentress 400 mg tablets. The contract, valued at $1,381.17, has an ultimate completion date of April 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive...
- This federal contract award, valued at $13,811.70, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Isentress 400 mg tablets, with a completion date of June 25, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $9,238.18 and covers the delivery of the pharmaceutical product Isentress 400 mg tablets. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F363GDelivery Order
On August 28, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $2,093.62 to DMS Pharmaceutical Group Inc. for the supply of Isentress 400 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of August 29, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's competitive capabilities in the federal pharmaceutical marketplace. The place of performance is Park Ridge, IL 60068. This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC framework enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards predominantly supporting military health facility medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/28/25 |